United States Veterinary Antibiotics Market Size, Competitive Landscape and Market Forecast - 2029

SKU: DMPH2407 | Last Updated On: Oct 19 2022 | Available Formats

> United States Veterinary Antibiotics Market Expected to reach a high CAGR of 5.10% By 2029: DataM Intelligence.

United States Veterinary Antibiotics Market is segmented By Drugs (Non-Steroidal Anti-Inflammatory Drugs (Aspirin or acetylsalicylic acid (Ecotrin, Aspirin, and others), Acetaminophen (Tylenol), Phenylbutazone (Butazolidin, VetriBute, Butatron, Phenylbute), Meclofenamate (Arquel), Tolfenamic Acid (Maxxtol), FLUNIXIN (Cronyxin), Others), Anti-parasitic (Simparica Trio™, ProHeart 12, Revolution, VETHICAL, Quest/Equest/Equest Pramox, Others), Anti-bacterial (Baytril (enrofloxacin), Chloramphenicol (brand names Chloromycetin and Viceton), Simbadol (buprenorphine injection), Apoquel (oclacitinib tablet), Convenia (cefovecin sodium), Others), Others), By Administration (Premixes, Injections, Oral Powders, Oral Solutions, Others), By End-User (Farm Animals, Companion Animals), By Distribution Channel (Veterinary Hospitals & Clinics, Pharmacies, Online Pharmacies, Others) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Market Overview

[150 Pages Report] The United States veterinary antibiotics market is expected to grow at a CAGR of 5.10% during the forecast period 2022-2029.

United States veterinary antibiotics market - Strategic Insights



Market CAGR


Segments Covered

By Drugs, By Administration, By End-User, By Distribution Channel and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To Get a Free Sample Click here

Antibiotics are the most important tools in a veterinarian’s toolbox as they cure bacterial disease in animals, without animals suffer or die from devastating diseases like anthrax or pneumonia. The use of antibiotics in animal agriculture helps to grow the demand for safe livestock-derived food such as meat, milk, and eggs.

According to the United States Food and Drug Administration (FDA), the annual sales of antibiotics for food-producing animals is increased every year, and by 26% in total.

The U.S sales of the critically important fluoroquinolone antibiotics were 20 tonnes in 2015, a 16% increase from 2014. In 2015, the total sales of medically important antibiotics in the US were 9,702 tonnes.

According to the United States Food and Drug Administration (FDA), in 2015, 74% of farm-animal antibiotics were administered in feed and 21% in drinking water.

Veterinary Antibiotics Market Drivers and Restraints:-

The increasing use of antibiotics in livestock is one of the factors fueling the United States veterinary antibiotics market. 

According to the Food and Drug Administration (FDA), around 12.3 million pounds of medically important antibiotics were sold for use in U.S. livestock and poultry in 2017.

In the US, livestock antibiotic use continues to account for about 64% of the sales of medically important antibiotics.

In the United States, around 80% of all antibiotics are given to cows, pigs, and chickens to make them grow more quickly or as a cheap alternative to keeping them healthy. In 2013, more than 131,000 tons of antibiotics were used in food animals worldwide, and it is expected to rise by 200,000 tons in 2030.

Segmentation Analysis

Based on product type the United States market for veterinary antibiotics is broadly segmented by an anti-parasitic, anti-bacterial, non-steroidal anti-inflammatory drug, and others.

Currently anti-parasitic is the dominant segment and it accounts for approximately XX% of the market, due to the launch of new products and facility expansion for anti-parasitic.

For instance, in January 2019, Bayer Animal Health has introduced Coraxis (moxidectin) Topical Solution for Dogs, a prescription-only, monthly transdermal product that prevents heartworm disease and treats and controls hookworms, roundworms, and whipworms in dogs. Coraxis is a unique addition to the veterinarian's anti-parasite toolbox.

In June 2018, UC San Diego has introduced a new center for anti-parasitic drug discovery and development to address this unmet need in global health. UC San Diego researchers use robotic technology to screen hundreds of thousands of chemical compounds from a variety of sources including drugs abandoned by pharmaceutical companies and marine natural products. Further, test the compounds in laboratory experiments and animal health.

Industry Competition in Veterinary Antibiotics Market:-

Some of the key players in the United States Veterinary Antibiotics market are Assisi Animal Health, Boehringer Ingelheim, Ceva, Chanelle Veterinary Limited, Dechra Pharmaceuticals Plc, Elanco, Intervet Inc., Northbrook, Vetoquinol S.A., and Zoetis.

The new technology development and product launch are driving the United States veterinary antibiotics market.

For instance, in August 2018, Bayer has introduced i-COWNT BRD a novel online comparison tool that is designed to help veterinarians make more informed treatment decisions for bovine respiratory disease (BRD). It is based on an independent mixed treatment comparison meta-analysis of BRD-treatment studies. I-COWNT BRD simplifies the analysis of scientific data to enable veterinarians to choose the most efficacious antibiotic for treatment.

In May 2016, Elanco Animal Health has introduced Integrity, a first-in-class, animal-use only, in-feed antibiotic developed for the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens in broiler chickens.

Why Purchase the Report?

  • Visualize the composition of the Veterinary Antibiotics market across each indication, regarding type and application highlighting the critical commercial assets and players.
  • Identify business opportunities in the Veterinary Antibiotics market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the Veterinary Antibiotics market-level 4/5 segmentation
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
  • Product mapping in excel for the key Veterinary Antibiotics market products of all major market players.

Target Audience

  • Raw Material Suppliers/ Buyers
  • Product Suppliers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Frequently Asked Questions

What is the Projected CAGR value of the United States veterinary antibiotics market ?

United States veterinary antibiotics market is expected to grow at a CAGR of 5.10% during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America region Controls theUnited States veterinary antibiotics market  during 2022-2029.

Which is the fastest growing region in the United States veterinary antibiotics market ?

Among all regions, Asia Pacific is the fastest growing market share during the forecast period.

Trending Topics

United States Veterinary Antibiotics Market

United States Veterinary Pain Management Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!